Embodied interaction control from human to artificial muscles
Interface Focus · 24.04.2026 · 16 (1)
DOI: 10.1098/rsfs.2025.0056 ↗Kurz gefasst
Fachartikel in der Zeitschrift Interface Focus, online erschienen am 24.04.2026. Verfasst von Etienne Burdet und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Soft actuators have been extensively developed over the past two decades, yet their control strategies remain rudimentary and do not exploit well their unique viscoelastic properties. To develop skilful control of soft actuators, we take inspiration from human sensorimotor control, which achieves dynamic and accurate movements despite relying on noisy and slow muscles. We first examine how the human nervous system (HNS) optimally controls muscles to exchange energy with the environment and extract maximal information from it. Critically, the HNS prepares interactions by learning specific patterns of reciprocal activation and co-activation, thereby regulating force and impedance, storing elastic energy and embodying uncertainty. We then show that soft actuators share key mechanical characteristics with human muscles and could thus benefit from recently identified computational mechanisms of the HNS, yielding efficient nonlinear adaptive impedance and stochastic nonlinear optimal control algorithms.
Zitieren
APA
Burdet, E., Xu, Y., & Taghavi, M. (2026). Embodied interaction control from human to artificial muscles. Interface Focus, 16(1). https://doi.org/10.1098/rsfs.2025.0056
Vancouver
Burdet E, Xu Y, Taghavi M. Embodied interaction control from human to artificial muscles. Interface Focus. 2026;16(1). doi:10.1098/rsfs.2025.0056
BibTeX
@article{Burdet2026,
author = {Burdet, Etienne and Xu, Yuejun and Taghavi, Majid},
title = {Embodied interaction control from human to artificial muscles},
journal = {Interface Focus},
year = {2026},
volume = {16},
number = {1},
doi = {10.1098/rsfs.2025.0056}
}
EUVIMED